Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorErasmus Medical Center
About this trial
This prospective, non-randomised, single centre, phase I trial assesses the clinical feasibility of the use of the patient-tailored ARCHITECT applicator in locally advanced cervical cancer brachytherapy.
Eligibility criteria
Qualifiers
Locally advanced cervical cancer (FIGO 2018 stage 1B3-IVA) with indication for primary radiotherapy including brachytherapy
Written informed consent
Disqualifiers
Unable to give informed consent;
Tumour extension in the lower 2/3rd of the vagina;
Requiring a Geneva tandem with ovoids' size 13 mm in the first application for brachytherapy;
Known nylon allergy.
Trial design
Treatments tested in this trial
- ARCHITECT applicator
Treatment groups
25 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov